Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,545 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Duration of remission of psoriasis therapies.
Koo J, Lebwohl M. Koo J, et al. J Am Acad Dermatol. 1999 Jul;41(1):51-9. doi: 10.1016/s0190-9622(99)70406-8. J Am Acad Dermatol. 1999. PMID: 10411411 Review.
Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?
Krueger GG, Feldman SR, Camisa C, Duvic M, Elder JT, Gottlieb AB, Koo J, Krueger JG, Lebwohl M, Lowe N, Menter A, Morison WL, Prystowsky JH, Shupack JL, Taylor JR, Weinstein GD, Barton TL, Rolstad T, Day RM. Krueger GG, et al. Among authors: koo j. J Am Acad Dermatol. 2000 Aug;43(2 Pt 1):281-5. doi: 10.1067/mjd.2000.106374. J Am Acad Dermatol. 2000. PMID: 10906652
Tazarotene plus UVB phototherapy in the treatment of psoriasis.
Koo JY, Lowe NJ, Lew-Kaya DA, Vasilopoulos AI, Lue JC, Sefton J, Gibson JR. Koo JY, et al. J Am Acad Dermatol. 2000 Nov;43(5 Pt 1):821-8. doi: 10.1067/mjd.2000.107940. J Am Acad Dermatol. 2000. PMID: 11050587 Clinical Trial.
Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks.
Weinstein GD, Koo JY, Krueger GG, Lebwohl MG, Lowe NJ, Menter MA, Lew-Kaya DA, Sefton J, Gibson JR, Walker PS; Tazarotene Cream Clinical Study Group. Weinstein GD, et al. Among authors: koo jy. J Am Acad Dermatol. 2003 May;48(5):760-7. doi: 10.1067/mjd.2003.103. J Am Acad Dermatol. 2003. PMID: 12734506 Clinical Trial.
Quality of life issues in psoriasis.
Choi J, Koo JY. Choi J, et al. Among authors: koo jy. J Am Acad Dermatol. 2003 Aug;49(2 Suppl):S57-61. doi: 10.1016/s0190-9622(03)01136-8. J Am Acad Dermatol. 2003. PMID: 12894127 Review.
Psoriasis.
Koo J, Lee E, Lee CS, Lebwohl M. Koo J, et al. J Am Acad Dermatol. 2004 Apr;50(4):613-22. doi: 10.1016/j.jaad.2003.11.046. J Am Acad Dermatol. 2004. PMID: 15034513 No abstract available.
2,545 results